<DOC>
	<DOC>NCT00676312</DOC>
	<brief_summary>This study is designed to investigate the safety and tolerability of PTH134 in healthy subjects and to assess the exposure from PTH134.</brief_summary>
	<brief_title>Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis, Postmenopausal</mesh_term>
	<criteria>Healthy postmenopausal female subjects, 40 to 70 years of age and in good health as determined by past medical history, physical examination, vital signs, electrocardiogram, and laboratory tests at screening Body mass index (BMI) within the range of 19 to 32. Smokers who report cigarette use of &gt;= 5 cigarettes per day. Use of any prescription drugs or overthecounter (OTC) medication (vitamins, herbal supplements, dietary supplements) started within the last month prior to screening. Previous osteoporosis treatment History of drug or alcohol abuse within the 12 months prior to dosing or evidence of such abuse Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>parathyroid hormone</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>